• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性类天疱疮的全身影响:连接皮肤科与内科

Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine.

作者信息

Mashima Emi, Saito-Sasaki Natsuko, Sawada Yu

机构信息

Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.

出版信息

Diagnostics (Basel). 2024 Oct 12;14(20):2272. doi: 10.3390/diagnostics14202272.

DOI:10.3390/diagnostics14202272
PMID:39451595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506695/
Abstract

: Bullous pemphigoid is an autoimmune bullous disease that frequently affects a large skin surface area, but it can also present in localized areas. It has been hypothesized that bullous pemphigoid affects the systemic functioning of different organs because inflammatory cells and cytokines circulate throughout numerous organs. : Recent clinical and experimental studies have revealed an association between bullous pemphigoid and systemic organ disorders. To avoid the emergence of systemic organ diseases, the significance of systemic treatment in cases of severe bullous pemphigoid should be emphasized. : Here, we discuss the specific molecular processes underlying typical systemic organ inflammatory diseases associated with bullous pemphigoids.

摘要

大疱性类天疱疮是一种自身免疫性大疱性疾病,常累及大面积皮肤,但也可局限于某些部位。据推测,大疱性类天疱疮会影响不同器官的全身功能,因为炎症细胞和细胞因子会在多个器官中循环。近期的临床和实验研究揭示了大疱性类天疱疮与全身器官疾病之间的关联。为避免全身器官疾病的出现,应强调在重症大疱性类天疱疮病例中进行全身治疗的重要性。在此,我们讨论与大疱性类天疱疮相关的典型全身器官炎症性疾病背后的具体分子过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/ce6f2c761b97/diagnostics-14-02272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/8c624b135f56/diagnostics-14-02272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/46af538d56f4/diagnostics-14-02272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/ce6f2c761b97/diagnostics-14-02272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/8c624b135f56/diagnostics-14-02272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/46af538d56f4/diagnostics-14-02272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc6/11506695/ce6f2c761b97/diagnostics-14-02272-g003.jpg

相似文献

1
Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine.大疱性类天疱疮的全身影响:连接皮肤科与内科
Diagnostics (Basel). 2024 Oct 12;14(20):2272. doi: 10.3390/diagnostics14202272.
2
Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.奥马珠单抗作为附加疗法治疗一线治疗耐药性黏膜类天疱疮和大疱性类天疱疮的快速疾病控制:13 例患者的病例系列。
Front Immunol. 2022 Apr 20;13:874108. doi: 10.3389/fimmu.2022.874108. eCollection 2022.
3
Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.大疱性类天疱疮和瘙痒性疾病老年患者的自身反应性外周血辅助性 T 细胞反应。
Front Immunol. 2021 Mar 25;12:569287. doi: 10.3389/fimmu.2021.569287. eCollection 2021.
4
Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis.病例报告:硬皮病和多发性硬化症患者并发大疱性类天疱疮。
Front Med (Lausanne). 2022 Dec 8;9:1055045. doi: 10.3389/fmed.2022.1055045. eCollection 2022.
5
Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid.靶向白细胞介素 4 和白细胞介素 13:天疱疮的一种新治疗方法。
Ann Med. 2023 Dec;55(1):1156-1170. doi: 10.1080/07853890.2023.2188487.
6
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.自身免疫性表皮下大疱性皮肤病:临床特征、诊断与治疗。
Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4.
7
Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.大疱性类天疱疮的严重程度和表型与针对BP180胞外域NH2端和COOH端区域的自身抗体谱相关。
J Invest Dermatol. 2002 Nov;119(5):1065-73. doi: 10.1046/j.1523-1747.2002.19529.x.
8
Bullous Pemphygoid and Novel Therapeutic Approaches.大疱性类天疱疮与新型治疗方法
Biomedicines. 2022 Nov 8;10(11):2844. doi: 10.3390/biomedicines10112844.
9
Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.与大疱性类天疱疮相关的BP180自身抗体可从培养的人角质形成细胞中释放白细胞介素-6和白细胞介素-8。
J Invest Dermatol. 2000 Nov;115(5):842-8. doi: 10.1046/j.1523-1747.2000.00141.x.
10
A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230.一项关于大疱性类天疱疮患者疾病严重程度与抗BP180和BP230自身抗体血清水平相关性的横断面研究。
Indian Dermatol Online J. 2021 Sep 10;12(5):696-700. doi: 10.4103/idoj.IDOJ_813_20. eCollection 2021 Sep-Oct.

本文引用的文献

1
Omalizumab and Dupilumab for the Treatment of Bullous Pemphigoid: A Systematic Review.奥马珠单抗和度普利尤单抗治疗大疱性类天疱疮:一项系统评价
J Clin Med. 2024 Aug 16;13(16):4844. doi: 10.3390/jcm13164844.
2
High serum total IgE levels correlate with urticarial lesions and IgE deposition in perilesional skin of bullous pemphigoid patients: An observational study.高血清总IgE水平与大疱性类天疱疮患者的荨麻疹样皮损及皮损周围皮肤IgE沉积相关:一项观察性研究。
Indian J Dermatol Venereol Leprol. 2025 Mar-Apr;91(2):204-209. doi: 10.25259/IJDVL_610_2023.
3
Study of cytokine-induced immunity in bullous pemphigoid: recent developments.
大疱性类天疱疮细胞因子诱导免疫研究:最新进展。
Ann Med. 2023;55(2):2280991. doi: 10.1080/07853890.2023.2280991. Epub 2023 Dec 18.
4
Adaptation to the Skin in Health and Persistent/Recurrent Infections.健康状态及持续性/复发性感染中对皮肤的适应
Antibiotics (Basel). 2023 Oct 7;12(10):1520. doi: 10.3390/antibiotics12101520.
5
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.奥马珠单抗治疗一线治疗抵抗性大疱性类天疱疮:一项法国全国多中心回顾性研究,纳入 100 例患者。
Br J Dermatol. 2024 Jan 23;190(2):258-265. doi: 10.1093/bjd/ljad369.
6
Evaluation of Dupilumab in Patients With Bullous Pemphigoid.评价度普利尤单抗治疗大疱性类天疱疮的疗效。
JAMA Dermatol. 2023 Sep 1;159(9):953-960. doi: 10.1001/jamadermatol.2023.2428.
7
Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid.靶向白细胞介素 4 和白细胞介素 13:天疱疮的一种新治疗方法。
Ann Med. 2023 Dec;55(1):1156-1170. doi: 10.1080/07853890.2023.2188487.
8
Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: A paradoxical reaction.两例银屑病患者在使用白细胞介素-17A 抑制剂后出现大疱性类天疱疮复发:一种矛盾反应。
J Dermatol. 2023 Jul;50(7):956-959. doi: 10.1111/1346-8138.16765. Epub 2023 Mar 7.
9
Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis.在没有二肽基肽酶-4 抑制剂的情况下,大疱性类天疱疮患者中糖尿病的患病率:系统评价和荟萃分析。
Arch Dermatol Res. 2023 Oct;315(8):2207-2213. doi: 10.1007/s00403-023-02562-0. Epub 2023 Mar 3.
10
Biologics for Reducing Cardiovascular Risk in Psoriasis Patients.用于降低银屑病患者心血管风险的生物制剂。
J Clin Med. 2023 Feb 1;12(3):1162. doi: 10.3390/jcm12031162.